NCT02704494View on ClinicalTrials.gov

Resveratrol's Effects in Diabetic Nephropathy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Diabetic Nephropathy
Interventions
DRUG

Resveratrol

Resveratrol 500mg daily

DRUG

Placebo

Placebo 1 capsule daily

DRUG

Losartan

Losartan 12.5mg daily

Trial Locations (1)

Unknown

Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT02704494 - Resveratrol's Effects in Diabetic Nephropathy | Biotech Hunter | Biotech Hunter